GleamWall
中文EN

CSTL CASTLE BIOSCIENCES INC

Services-Medical Laboratories · Nasdaq · SEC CIK 1447362 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY-88.1%
TTM EPS YoY-72.7%
Revenue 3-yr CAGR25.2%
Net income 3-yr CAGR—

Margins

Gross margin77.1%
Operating margin-7.4%
Net margin-6.1%
FCF margin1.1%
EBITDA margin-4.4%

Returns

ROE-4.9%
ROA-4.0%
ROIC (approx.)-5.5%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets17.4%
Debt / equity0.02x
Current ratio5.28x
Interest coverage-51.16x

Cash quality & payout

Operating cash flow / net income-1.73x
Accruals ratio-11.0%
Payout ratio—
Capex / revenue9.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$344.23M$332.07M
Cost of revenue$71.03M$60.20M
Gross profit$273.20M$271.86M
R&D expense$51.85M$52.04M
SG&A expense$229.32M$200.05M
Operating income-$42.81M$8.67M
Interest expense$86,000$577,000
Income tax-$5.36M$3.32M
Net income-$24.16M$18.25M
EBITDA-$2.04M$24.67M
EPS (basic)-0.830.66
EPS (diluted)-0.830.62
Dividends declared per share0.000.00
Weighted avg. shares (diluted)28.99M29.25M
Balance sheet
Cash & equivalents$116.73M$119.71M
Short-term investments$182.78M$173.42M
Receivables$43.38M$51.22M
Inventory$10.25M$8.13M
Current assets$361.10M$360.15M
PP&E, net$97.44M$51.12M
Goodwill$10.70M$10.70M
Intangibles$88.88M$95.54M
Total assets$578.56M$531.24M
Current liabilities$68.68M$49.39M
Short-term debt$417,000$278,000
Long-term debt$9.64M$9.74M
Total debt$10.06M$10.02M
Total liabilities$107.68M$75.40M
Shareholders' equity$470.87M$455.83M
Net debt-$106.67M-$109.69M
Shares outstanding29.69M28.48M
Cash flow statement
Operating cash flow$64.35M$64.87M
Capital expenditure$36.02M$28.33M
Free cash flow$28.33M$36.54M
Investing cash flow-$60.37M-$50.14M
Financing cash flow-$6.96M$6.14M
Depreciation & amortization$40.77M$16.00M
Stock-based compensation$45.89M$50.32M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.